Soluble urokinase plasminogen activator receptor (suPAR) in children with obesity or type 1 diabetes as a marker of endothelial dysfunction: a cross-sectional study
Eirini Kostopoulou, Dimitra Kalavrizioti, Panagiota Davoulou, Xenophon Sinopidis, Evangelos Papachristou, Dimitrios Goumenos, Gabriel Dimitriou, Bessie E. Spiliotis, Marios Papasotiriou
Topics & Concepts
SuPARMedicineInternal medicineCreatininePlasminogen activatorBody mass indexGastroenterologyEndocrinologyInsulin resistanceType 1 diabetesDiabetes mellitusEndothelial dysfunctionProteinuriaObesityUrokinase receptorKidneyAdipokines, Inflammation, and Metabolic DiseasesProtease and Inhibitor MechanismsBlood properties and coagulation